Levothyroxine Sodium News
LCI: Receives FDA Approval for Phentermine HCI Capsules - Trading Markets (press release)
The Company has also successfully launched a number of new products such as "AB Rated" Levothyroxine Sodium tablets and Digoxin tablets. ...
LCI: Receives FDA Approval for Phentermine HCI Capsules - Trading Markets (press release)
The Company has also successfully launched a number of new products such as "AB Rated" Levothyroxine Sodium tablets and Digoxin tablets. ...
Lannett Reports Fiscal 2008 First Quarter Financial Results - Business Wire (press release)
Bedrosian added, “Sales of our Levothyroxine sodium product, the only Levothyroxine product of its kind on the market that meets the FDA’s new and more ...
Lannett Reports Fiscal 2008 First Quarter Financial Results - Business Wire (press release)
Bedrosian added, “Sales of our Levothyroxine sodium product, the only Levothyroxine product of its kind on the market that meets the FDA’s new and more ...
Lannett Reports Fiscal 2008 First Quarter Financial Results - PharmaLive.com (press release)
Bedrosian added, "Sales of our Levothyroxine sodium product, the only Levothyroxine product of its kind on the market that meets the FDA's new and more ...
Lannett Comments on Recent FDA Announcement for Levothyroxine Sodium - Compliance Home
Jerome Stevens’ Levothyroxine sodium products meet the new specifications for potency announced by FDA. “We applaud the FDA’s decision to implement a ...
Lannett Company Comments on Recent FDA Announcement for ... - PR-Inside.com (Pressemitteilung)
Jerome Stevens' Levothyroxine sodium products meet the new specifications for potency announced by FDA. "We applaud the FDA's decision to implement a ...
King Pharmaceuticals Reports Third-Quarter 2007 Financial Results - PharmaLive.com (press release)
LEVOXYL(R) (levothyroxine sodium tablets, USP) net sales decreased to $21 million during the third quarter ended September 30, 2007 from $25 million during ...
FDA: ensuring potency of thyroid drugs - NEWSFOOD.com Primo piano
FDA is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure that ...
FDA Acts to Ensure Thyroid Drugs Don’t Lose Potency Before ... - WebWire (press release)
The US Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other ...
Levothyroxine Sodium RSS Feed